Feng-Lin Lu

585 total citations
14 papers, 490 citations indexed

About

Feng-Lin Lu is a scholar working on Molecular Biology, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Feng-Lin Lu has authored 14 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Clinical Biochemistry. Recurrent topics in Feng-Lin Lu's work include Genomics, phytochemicals, and oxidative stress (4 papers), Acute Ischemic Stroke Management (3 papers) and Advanced Glycation End Products research (3 papers). Feng-Lin Lu is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (4 papers), Acute Ischemic Stroke Management (3 papers) and Advanced Glycation End Products research (3 papers). Feng-Lin Lu collaborates with scholars based in China, United Kingdom and Singapore. Feng-Lin Lu's co-authors include Jing‐Zhou Wang, Qingwu Yang, Jingcheng Li, Jing Xiang, Yu Zhou, Sen Lin, Qi Zhong, Yiguo Zhang, Lin Wang and Lili Zhang and has published in prestigious journals such as Scientific Reports, FEBS Letters and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Feng-Lin Lu

13 papers receiving 483 citations

Peers

Feng-Lin Lu
Yu‐I Li Taiwan
Hoonsung Choi South Korea
Arjun Sapkota South Korea
Xiyu Mei China
Dezhen Tu China
Yu‐I Li Taiwan
Feng-Lin Lu
Citations per year, relative to Feng-Lin Lu Feng-Lin Lu (= 1×) peers Yu‐I Li

Countries citing papers authored by Feng-Lin Lu

Since Specialization
Citations

This map shows the geographic impact of Feng-Lin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng-Lin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng-Lin Lu more than expected).

Fields of papers citing papers by Feng-Lin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng-Lin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng-Lin Lu. The network helps show where Feng-Lin Lu may publish in the future.

Co-authorship network of co-authors of Feng-Lin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Feng-Lin Lu. A scholar is included among the top collaborators of Feng-Lin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng-Lin Lu. Feng-Lin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Ren, Yonggang, Lu Qiu, Feng-Lin Lu, et al.. (2016). TALENs-directed knockout of the full-length transcription factor Nrf1α that represses malignant behaviour of human hepatocellular carcinoma (HepG2) cells. Scientific Reports. 6(1). 23775–23775. 35 indexed citations
3.
Chen, Jiayu, Xiping Liu, Feng-Lin Lu, et al.. (2015). Transcription factor Nrf1 is negatively regulated by its O‐GlcNAcylation status. FEBS Letters. 589(18). 2347–2358. 27 indexed citations
4.
Cao, Zheng & Feng-Lin Lu. (2013). The Virosome as a Novel Concept for High Pathogenic Porcine Reproductive and Respiratory Syndrome Virus (HP-PRRSV) Vaccines. Journal of Integrative Agriculture. 12(7). 1215–1224. 2 indexed citations
5.
Lu, Feng-Lin, et al.. (2013). Mechanisms Underlying Chemopreventive Effects of Flavonoids via Multiple Signaling Nodes within Nrf2-ARE and AhR-XRE Gene Regulatory Networks. Current Chemical Biology. 7(2). 151–176. 23 indexed citations
6.
Zhong, Julia Li, Yang Li, Feng-Lin Lu, et al.. (2011). UVA, UVB and UVC Induce Differential Response Signaling Pathways Converged on the eIF2α Phosphorylation. Photochemistry and Photobiology. 87(5). 1092–1104. 32 indexed citations
7.
Yang, Qingwu, Feng-Lin Lu, Yu Zhou, et al.. (2010). HMBG1 Mediates Ischemia—Reperfusion Injury by TRIF-Adaptor Independent Toll-Like Receptor 4 Signaling. Journal of Cerebral Blood Flow & Metabolism. 31(2). 593–605. 124 indexed citations
8.
Zhou, Yu, Kunlin Xiong, Sen Lin, et al.. (2010). Elevation of High-Mobility Group Protein Box-1 in Serum Correlates with Severity of Acute Intracerebral Hemorrhage. Mediators of Inflammation. 2010. 1–6. 61 indexed citations
9.
Yang, Qingwu, Jing‐Zhou Wang, Jingcheng Li, et al.. (2009). High-Mobility Group Protein Box-1 and its Relevance to Cerebral Ischemia. Journal of Cerebral Blood Flow & Metabolism. 30(2). 243–254. 77 indexed citations
10.
Gu, Yu & Feng-Lin Lu. (2009). Vascular endothelial growth factor promotes the invasion of human hepatocellular carcinoma SMMC-7721 cells via an autocrine mechanism. World Chinese Journal of Digestology. 17(32). 3292–3292. 1 indexed citations
11.
Yang, Qingwu, Jingcheng Li, Feng-Lin Lu, et al.. (2008). Upregulated Expression of Toll-Like Receptor 4 in Monocytes Correlates with Severity of Acute Cerebral Infarction. Journal of Cerebral Blood Flow & Metabolism. 28(9). 1588–1596. 97 indexed citations
12.
Hu, Mei, et al.. (2008). A novel vector of topological and structural information for amino acids and its QSAR applications for peptides and analogues. Science in China Series B Chemistry. 51(10). 946–957. 6 indexed citations
13.
14.
Wu, Zhenhong, et al.. (2003). Blocking effects of anti-sense peptide of C5a on the adhesion between pulmonary vascular endothelial cell and neutrophil. Zhongguo mianyixue zazhi. 19(10). 672–676. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026